Demographic | Article % |
---|---|
Funding source | |
 private | 50.0% (23/46) |
 public | 43.5% (20/46) |
 not mentioned/other | 21.7% (10/46) |
 industry | 10.9% (5/46) |
 hospital | 4.3% (2/46) |
 Study design | |
 parallel arm | 73.7% (35/46) |
 crossover | 13.0% (6/46) |
 factorial | 8.7% (4/46) |
 Intervention | |
 pharmacological | 76.1% (35/46) |
 non-pharmacological | 23.9% (11/46) |
Blinding | |
 no blinding/not specified | 69.6% (32/46) |
 double-binded | 21.7% (10/46) |
 single-blinded | 8.7% (4/46) |
Stated adherence to TIDieR | |
 no | 100% (46/46) |
 yes | 0% (0/46) |